证券研究报告 | 2025年05月06日 荃银高科（300087.SZ） 优于大市 2024 年报及 2025 一季报点评：毛利率下降，减值计提增加， 公司盈利承压 毛利率下降，减值计提增加，归母净利润同比下滑。公司 2024 年实现营业 收入 47.09 亿元，同比+14.77%，主要得益于订单粮食、种子业务收入 增长；实现归属于母公司所有者的净利润 1.14 亿元，同比-58.23%，盈 利下滑明显的原因一方面系公司主业毛利率下滑，另一方面系公司减值 计提增加，其中资产减值损失增加约 1.1 亿元，信用减值损失增加约 0.8 亿元。分季度来看，公司 2025Q1 实现营业收入 8.35 亿元，同比+24.13%， 主要得益于订单粮食及出口业务收入增长；实现归属于母公司所有者的 净利润 0.02 亿元，同比-87.62%，主要受种子业务毛利率下滑影响。 玉米种子量利齐增，水稻种子毛利率下降。2024 年公司水稻种子实现营业 收入 18.58 亿元，同比+5.67%，实现毛利 7.40 亿元，同比-1.73%，对 应毛利率为 39.81%，同比-3.00pct；玉米种子实现营业收入 5.89 亿元， 同比+2 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 据智通财经4月28日消息，立方数科(300344.SZ)公告称，公司于2025年4月28日收到证监会下发的《立 案告知书》，因定期报告涉嫌信息披露违法违规，证监会决定对公司立案。立案调查期间，公司将积极 配合证监会的各项工作，严格按照规定及监管要求履行信息披露义务。公司生产经营情况一切正常，上 述事项不会影响公司正常的生产经营活动。 回天新材：终止投资建设回天新能源新材料技术产业园项目 据智通财经4月27日消息，回天新材(300041.SZ)公告称，公司于2025年4月25日召开第十届董事会第二 次会议，审议通过了《关于终止投资建设回天新能源新材料技术产业园项目的议案》，同意终止在合肥 市肥东县投资建设回天新能源新材料技术产业园项目。 据4月28日盘后口子窖发布2024年报及一季报公告，2024年报显示，公司实现营业收入60.15亿元，同比 增长0.89%，增速相比于上年有所放缓；利润总额达到22.74亿元，同比减少2.32%；实现归母净利润 16.55亿元，同比减少3.83%。报告期内，白酒库存量同比增长27%，增速高于当期白酒产量与销量。 宝馨科技：收到两 ...

Core Viewpoint - The company reported a revenue increase of 14.77% in 2024, but net profit decreased by 58.23% due to various factors including declining seed gross margins and increased operating expenses [1][2][3] Financial Performance - In 2024, the company achieved a revenue of 4.709 billion yuan, up from the previous year, primarily driven by increased seed exports and domestic corn seed sales [2][3] - The company's net profit for 2024 was 114 million yuan, a significant decline of 58.23% compared to the previous year, resulting in a decrease of 160 million yuan [2][3] Revenue Breakdown - The largest revenue source was rice seed sales, generating 1.858 billion yuan, a growth of 5.67% year-on-year [2] - Corn seed sales reached 589 million yuan, marking a 20.43% increase [2] - The fastest growth came from order grain and silage feed, which generated 1.191 billion yuan, up 44.22% [2] Profitability Issues - The decline in net profit was attributed to three main factors: reduced gross margins in seed business due to increased competition, higher research and management expenses, and significant impairment losses [3][4] - The company reported total impairment losses of 238 million yuan, including credit impairment losses on receivables and inventory write-downs [3][4] Audit Concerns - The audit firm KPMG issued a qualified opinion on the financial statements due to two key issues: the existence and valuation of certain receivables and the accuracy of inventory valuation [1][5] - The first issue involved receivables related to grain sales, where the company failed to provide sufficient evidence for the existence and accuracy of the amounts [5][6] - The second issue pertained to the valuation of inventory, where the company could not substantiate its sales forecasts for corn seed inventory, leading to questions about the adequacy of inventory write-downs [7][8] Management Response - The company plans to assign personnel to pursue the collection of receivables from three grain sales companies and aims to recover the amounts within two years [8] - For the corn seed inventory, the company intends to implement various measures to ensure sales over the next two years [8]

Core Viewpoint - The company, Qianyin Gaoke, reported a steady growth in revenue and net profit for 2024 and Q1 2025, driven by increased sales in its seed business, particularly in rice and corn [2][3][4]. Financial Performance - In 2024, the company achieved a revenue of 4.709 billion yuan, a year-on-year increase of 14.77%, with a net profit of 114 million yuan [2]. - For Q1 2025, the company reported a revenue of 835 million yuan, up 24.13% year-on-year, with a net profit of 2.197 million yuan [2]. - The company aims to reach a revenue target of 5 billion yuan and a net profit of 300 million yuan for 2025 [2]. Seed Business Overview - The rice seed sales revenue reached 1.858 billion yuan in 2024, a growth of 5.67%, with a total sales volume of 216 million kilograms, up nearly 7% [3]. - The corn seed segment generated a revenue of 589 million yuan in 2024, reflecting a 20.43% increase, with a gross margin of 33.15% [4]. Innovation and Patents - The company received a national patent for a method of creating broadly resistant transgenic corn, marking a significant advancement in disease-resistant crop development [5]. - In 2024, 59 new rice varieties and 13 new corn varieties were approved, enhancing the company's competitive edge in the market [3][4]. International Market Development - In 2024, the company exported 19.3735 million kilograms of seeds, a 74.80% increase year-on-year, generating an overseas revenue of 492 million yuan, up 72.39% [6][7]. - The company is actively pursuing international breeding collaborations to expand its global market presence [7]. Audit and Financial Health - The company maintains that its accounts receivable and inventory valuations are accurate, and it plans to take measures to recover outstanding receivables over the next two years [8]. - The Q1 2025 report indicated a debt ratio of 62.94%, with a gross margin of 13.48% [8].

Core Viewpoint - The company reported a revenue increase of 14.77% in 2024, but net profit decreased by 58.23% due to various factors including declining seed gross margins and increased operating expenses [1][5][6]. Financial Performance - In 2024, the company achieved a revenue of 4.709 billion yuan, up from the previous year, primarily driven by increased seed exports and domestic corn seed sales [5][6]. - The sales revenue from rice seeds was 1.858 billion yuan, a year-on-year increase of 5.67%, while corn seed sales reached 589 million yuan, growing by 20.43% [5]. - The fastest growth came from order grain and silage feed, which generated 1.191 billion yuan, marking a 44.22% increase [5]. Profitability Issues - The company reported a net profit of 114 million yuan, down 58.23% from the previous year, resulting in a decrease of 160 million yuan [1][6]. - The decline in net profit was attributed to three main factors: reduced gross margins in seed business, increased R&D and operating expenses, and significant impairment losses [6][7]. Impairment Losses - The total impairment losses for the year amounted to 238 million yuan, which significantly impacted the net profit [6][7]. - Specific impairment losses included 85.6686 million yuan for accounts receivable, 21.6848 million yuan for other receivables, and 80.7006 million yuan for inventory [6][7]. Audit Concerns - The company's financial statements received a qualified opinion from the auditing firm due to two key issues: the existence and accuracy of certain receivables and the valuation of inventory [7][8]. - The first issue involved accounts receivable related to grain sales, where the company could not confirm the existence and accuracy of 32.7759 million yuan in receivables [7][8]. - The second issue pertained to the valuation of inventory, where the company failed to provide sufficient evidence to support its sales forecasts for corn seed inventory [8][9]. Management Response - The company plans to actively pursue the collection of receivables from three grain sales companies and aims to recover the amounts within two years [9]. - For the corn seed inventory, the company intends to implement various measures to ensure sales within the next two years [9].

证券代码：300087 证券简称：荃银高科 公告编号：2025-024 安徽荃银高科种业股份有限公司 关于第二期员工持股计划第二个解锁期 业绩考核目标未达成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 公司于2019年3月11日至2019年11月19日回购股份18,134,236 股。2020 年 12 月 16 日，公司将回购专用证券账户中的 9,170,000 股 股票非交易过户至"安徽荃银高科种业股份有限公司—第一期员工持 股计划"专用证券账户。2022 年 11 月 14 日，公司将回购专用证券 账户中剩余的 8,964,236 股非交易过户至"安徽荃银高科种业股份有 限公司—第二期员工持股计划"专用证券账户。 根据第二期员工持股计划（草案），本员工持股计划的存续期为 60 个月，自公司公告标的股票过户至员工持股计划名下之日起算。 存续期的前 12 个月为锁定期，锁定期届满后，股票分三批解锁，自 公司分别公告 2023 年年度报告、2024 年年度报告、2025 年年度报告 后解锁本期员工持股计划总数的 50%、30%、20%。 第二期员工持 ...

证券代码：300087 证券简称：荃银高科 4、请介绍公司抗病转基因玉米专利情况。 安徽荃银高科种业股份有限公司投资者关系活动记录表 编号：2025-001 | | ☑特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活动 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | 类别 | □现场参观 | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及 | 国泰海通 林逸丹；明泽投资 杨伟；天治基金 王策源；旭芽 | | 人员姓名 | 私募 裘峥；东兴证券 朱佳怡；禾永投资 杨正陶；冰河资产 刘 | | | 春茂；循远资产 田超平。 | | 时间 | 年 月 日 15：30-16：15 2025 4 30 | | 地点 | 公司 420 办公室 | | 上市公司接待人 | 董事会秘书 张庆一；证券事务代表 王允利 | | 员姓名 | | | | 1、请介绍公司2024年及2025年一季度的业绩情况。 2024年度公司实现营业收入47.09亿元，同比增长14.77%； | | | 归属于上市公司股东的净利润1.14亿元，公司种业收入和销量 | | | ...

Core Insights - The company reported a revenue of 4.709 billion yuan for 2024, marking a year-on-year increase of 14.77% and a net profit of 114 million yuan, driven by steady growth in seed sales and exports [1] - The company achieved a total seed sales volume of 21,620.91 million kilograms, reflecting a year-on-year growth of 6.81%, with significant increases in rice and corn sales [1] - The company has enhanced its breeding innovation capabilities, with 59 new rice varieties and 19 hybrid corn varieties passing national certification in 2024 [1] Group 1 - The company has optimized its business structure by establishing dedicated divisions for rice and corn, exploring a new marketing model that integrates "advantage products + services" [2] - The company has expanded its sales network across 17 provinces and cities in China, strengthening market control and combating infringement [2] - The company’s overseas sales reached 19,373.48 tons, a 74.80% increase year-on-year, with overseas revenue of 492 million yuan, up 72.39% [2] Group 2 - The company reported a revenue of 835.32 million yuan for Q1 2025, a 24.13% increase compared to the same period last year, attributed to increased seed exports and grain orders [3] - The net profit for Q1 2025 was 2.197 million yuan, indicating positive growth in the company's financial performance [3]

安徽荃银高科种业股份有限公司 董事会关于 2024 年度财务审计报告保留意见涉及事项的专项说明 毕马威华振会计师事务所（特殊普通合伙）（以下简称"毕马威"）对安徽 荃银高科种业股份有限公司（以下简称"公司"或"荃银高科"）2024 年度财 务报告出具了保留意见的审计报告。 一、审计报告中形成保留意见的基础 （一）销售酒粮业务所产生的应收款项的存在性和账面价值的准确性 如财务报表附注五、4 和附注五、6 所述，于 2024 年 12 月 31 日，荃银高科 合并资产负债表的应收账款中包括子公司四川荃银生物有限责任公司（以下简称 "四川荃银生物" ）与三家酒厂因酒粮销售相关的交易而确认的应收账款人民 币 3,277.59 万元（2023 年 12 月 31 日：人民币 3,277.59 万元），坏账准备余额 为人民币 816.12 万元（2023 年 12 月 31 日：人民币 65.55 万元），账面价值为 人民币 2,461.47 万元（2023 年 12 月 31 日：人民币 3,212.04 万元），以及与贵 州某公司的其他应收款原值人民币 688.29 万元（2023 年 12 月 31 日：人民币 6 ...

安徽荃银高科种业股份有限公司 关于中化集团财务有限责任公司 2024 年度风险评估报告 根据中国证券监督管理委员会、深圳证券交易所的相关要求，安徽荃银高科 种业股份有限公司（以下简称"本公司"）通过查验中化集团财务有限责任公司 （以下简称"中化财务公司"或"公司"）《金融许可证》《营业执照》等证件 资料，并审阅了中化财务公司验资及审计报告，对中化财务公司的经营资质、业 务和风险状况进行了评估，现将有关风险评估情况报告如下： 一、中化财务公司基本情况 （一）企业历史沿革、注册地、组织形式和总部地址 中化集团财务有限责任公司系经原中国银行保险监督管理委员会（现为国家 金融监督管理总局）批准，由中国中化集团有限公司（以下简称"中化集团"） 出资，在北京成立的有限责任公司。公司于2008年6月4日在国家市场监督管理总 局办理了工商登记，企业法人营业执照注册号：100000000041669；法定代表人： 陈国钢；注册资本600,000万元；注册地：北京市西城区复兴门内大街28号凯晨 世贸中心中座F3层；总部地址：北京西城区。本公司于2023年8月8日变更营业执 照，法定代表人变更为夏宇。社会统一信用代码证号为9111 ...